GenomeNet

Database: CarbBank
Entry: 11788 12059 13970 14304 15546 15728 16326 17359 17366 21098 21144 21317 24772 28504 32937 33330 33612 47762 8838 980
LinkDB: 11788 12059 13970 14304 15546 15728 16326 17359 17366 21098 21144 21317 24772 28504 32937 33330 33612 47762 8838 980
CC: CCSD:11788
AU: Kannagi R; Levery SB; Ishigami F; Hakomori S; Shevinsky LH; Knowles
    BB; Solter D
TI: New globoseries glycosphingolipids in human teratocarcinoma reactive
    with the monoclonal antibody directed to a developmentally regulated
    antigen, stage-specific embryonic antigen 3
CT: J Biol Chem (1983) 258: 8934-8942 [PMID:6863318]
BS: (CN) human, (OT) teratocarcinoma, (disease) cancer
TN: V2Fuc-Gb5-Cer
AN: cancer-associated antigen
MT: glycolipid
MT: glycosphingolipid
AM: 1H-NMR
AM: GC-MS
SB: Doubet S
DA: 23-01-1992
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:12059
AU: Bremer EG; Levery SB; Sonnino S; Ghidoni R; Canevari S; Kannagi R;
    Hakomori S
TI: Characterization of a glycosphingolipid antigen defined by the
    monoclonal antibody MBr1 expressed in normal and neoplastic epithelial
    cells of human mammary gland
CT: J Biol Chem (1984) 259: 14773-14777 [PMID:6501317]
BS: (CN) human, (OT) mammary
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
AM: 1H-NMR
AM: GC-MS
SB: Karlsson KA
DA: 22-04-1989
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:13970
AU: Larson G
TI: Globoseries glycosphingolipids of human meconium
CT: Arch Biochem Biophys (1986) 246: 531-545 [PMID:3010864]
BS: (CN) human, (OT) meconium
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
AM: 1H-NMR
AM: MS
SB: Hansen LBL
DA: 23-11-1993
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:14304
AU: Furukawa K; Clausen H; Hakomori S; Sakamoto J; Look K; Lundblad A;
    Mattes MJ; Lloyd KO
TI: Analysis of the specificity of five murine anti-blood-group A
    monoclonal antibodies, including one that identifies type 3 and type 4 A
    determinants
CT: Biochemistry (1985) 24: 7820-7826 [PMID:2418872]
SC: Globo-H
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
SB: Stuike-Prill R
DA: 04-01-1992
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:15546
AU: Fenderson BA; Andrews PW; Nudelman E; Clausen H; Hakomori SI
TI: Glycolipid core structure switching from globo- to lacto- and ganglio-
    series during rentinoic acid-induced differentiation of TERA-2-derived
    human embryonal carcinoma cells
CT: Dev Biol (1987) 122: 21-34 [PMID:3297853]
BS: (CN) human, (LS) embryo, (disease) cancer
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
SB: Kleen A
DA: 04-01-1992
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:15728
AU: Senior D; Baker N; Cedergren B; Falk P; Larson G; Lindstedt R; Eden CS
TI: Globo-A - a new receptor specificity for attaching Escherichia coli
CT: FEBS Lett (1988) 237: 123-127 [PMID:3049148]
SC: H type 4 chain (globo-H)
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
SB: Kleen A
DA: 04-01-1992
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:16326
AU: Lindberg AA; Brown JE; Stroemberg N; Westling-Ryd M; Schultz JE;
    Karlsson KA
TI: Identification of the carbohydrate receptor for Shiga toxin produced
    by Shigella dysenteriae type 1
CT: J Biol Chem (1987) 262: 1779-1785 [PMID:3543013]
SC: 6
BS: (CN) human, (OT) meconium
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
SB: Kleen A
DA: 04-01-1992
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:17359
AU: Kannagi R; Watanabe K; Hakomori S
TI: Isolation and purification of glycosphingolipids by high-performance
    liquid chromatography
CT: Methods Enzymol (1987) 138: 3-12 [PMID:3600327]
SC: x3a
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
AM: HPLC
SB: Hansen LBL
DA: 06-02-1994
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:17366
AU: Levery SB; Hakomori S
TI: Microscale methylation analysis of glycolipids using capillary gas
    chromatography-chemical ionization mass fragmentography with selected ion
    monitoring
CT: Methods Enzymol (1987) 138: 13-25 [PMID:3600318]
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
AM: GC-MS
SB: Kleen A
DA: 04-01-1992
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:21098
AU: Lindstedt R; Baker N; Falk P; Hull R; Hull S; Karr J; Leffler H; Eden
    CS; Larson G
TI: Binding specificities of wild-type and Cloned Escherichia coli
    strains that recognize globo-A
CT: Infect Immun (1989) 57: 3389-3394 [PMID:2572551]
SC: H type 4 chain (globo-H)
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
SB: Doubet S
DA: 04-01-1992
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:21144
AU: Lindstedt R; Larson G; Falk P; Jodal U; Leffler H; Svanborg C
TI: The receptor repertoire defines the host range for attaching
    Escherichia coli strains that recognize globo-A
CT: Infect Immun (1991) 59: 1086-1092 [PMID:1671774]
SC: 4
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
SB: Kleen A
DA: 04-01-1992
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:21317
AU: Holgersson J; Jovall PA; Samuelsson BE; Breimer ME
TI: Structural characterization of non-acid glycosphingolipids in kidneys
    of single blood-group O and A pigs
CT: J Biochem (1990) 108: 766-777 [PMID:2081734]
BS: (CN) pig, (OT) kidney
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
SB: Doubet S
DA: 04-01-1992
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:24772
AU: Kimura H; Taki T; Hoshi S; Yamamoto S; Matsumoto M
TI: Asialogangliosides as differentiation markers of rat erythropoietic
    and granulopoietic cells in rat bone marrow. Flow cytometric analysis of
    rat bone marrow cells using anti-asialoganglioside antibodies
CT: Cell Struct Funct (1986) 11: 89-97 [PMID:3731286]
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
SB: Doubet S
DA: 04-01-1992
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:28504
AU: Tsuchiya K; Suzuki Y; Mabuchi K; Suzuki T; Hirabayashi Y; Sakiyama H
TI: Characterization of sialyltransferase of B16 melanoma cells involved
    in the formation of melanoma-associated antigen GM3
CT: J Clin Biochem Nutr (1993) 14: 141-149
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
SB: Doubet S
DA: 27-11-1993
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:32937
AU: Lay L; Nicotra F; Panza L; Russo G; Adobati E
TI: Oligosaccharides related to tumor-associated antigens. Part 1.
    Synthesis of the propyl glycoside of the trisaccharide .alpha.-L-Fucp-(1-2)-.beta.-D-
    Galp-(1-3)-.beta.-D-GalpNAc, component of a tumor antigen recognized by the
    antibody MBr1
CT: Helv Chim Acta (1994) 77: 509-514
SC: 1
TN: V2Fuc-Gb5-Cer
ST: synthetic
MT: glycolipid
MT: glycosphingolipid
SB: Kleen A
DA: 28-10-1994
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:33330
AU: Toma L; Ciuffreda P; Colombo D; Ronchetti F; Lay L; Panza L
TI: Oligosaccharides related to tumor-associated antigens
CT: Helv Chim Acta (1994) 77: 668-678
SC: 1
BS: (CN) human, (OT) breast, (disease) cancer
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
SB: Doubet S
DA: 05-10-1994
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:33612
AU: King MJ
TI: Blood group antigens on human erythrocytes-distribution, structure
    and possible functions
CT: Biochim Biophys Acta (1994) 1197: 15-44 [PMID:8155690]
BS: (CN) human, (OT) erythrocyte
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
NT: review article
SB: van Kuik A
DA: 13-10-1994
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:47762
AU: Bock K; Breimer ME; Brignole A; Hansson GC; Karlsson KA; Larson G;
    Leffler H; Samuelsson BE; Stromberg N; Eden CS; Thurin J
TI: Specificity of binding of a strain of uropathogenic Escherichia coli
    to Gal.alpha.1-4Gal-containing glycosphingolipids
CT: J Biol Chem (1985) 260: 8545-8551 [PMID:3891756]
SC: 7
BS: (CN) human, (OT) meconium
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
SB: Westra B
DA: 27-02-1996
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:8838
AU: Clausen H; Watanabe K; Kannagi R; Levery SB; Nudelman E; Arao-Tomono
    Y; Hakomori S
TI: blood-group A glycolipid (Ax) with globo-series structure which is
    specific for blood-group A1 erythrocytes: one of the chemical bases for
    A1 and A2 distinction
CT: Biochem Biophys Res Commun (1984) 124: 523-529 [PMID:6497890]
BS: (GT) blood-group A1, (OT) AX erythrocyte
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
SB: Doubet S
DA: 04-01-1992
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
CC: CCSD:980
AU: Kannagi R; Levery SB; Hakomori S
TI: blood-group H antigen with globo-series structure: isolation and
    characterization from human blood-group O erythrocytes
CT: FEBS Lett (1984) 175: 397-401 [PMID:6479351]
BS: (CN) human, (GT) blood-group O, (OT) erythrocyte
TN: V2Fuc-Gb5-Cer
MT: glycolipid
MT: glycosphingolipid
AM: 1H-NMR
AM: HPLC
AM: MS
SB: Karlsson KA
DA: 22-04-1989
FC: 5f92e542
SI: CBank:17176
----------------
structure:

 a-L-Fucp-(1-2)-b-D-Galp-(1-3)-b-D-GalpNAc-(1-3)-a-D-Galp-(1-4)-b-D-Galp-(1-4)-b-D-Glcp-(1-1)-Ceramide
================end of record
DBGET integrated database retrieval system